Keyboard shortcuts

Press ← or → to navigate between chapters

Press S or / to search in the book

Press ? to show this help

Press Esc to hide this help

The EHDS EHR system: intended purpose

Revised 2026-10-08.

This page is the statement by Cadasto B.V., the manufacturer, of the use it intends the EHR system that FerroEHR and FerroBRIDGE form together for: what the system is for, who uses it, which data it is designed to process, how it is operated, and what the intended purpose excludes. Each product’s book carries its own part of the statement: its essential functions, the data it holds, the environment it relies on, and the use and misuse that can be foreseen for it.

Two regulations measure the system against this statement. The Cyber Resilience Act (CRA, Regulation (EU) 2024/2847) defines the intended purpose as “the use for which a product with digital elements is intended by the manufacturer, including the specific context and conditions of use, as specified in the information supplied by the manufacturer in the instructions for use, promotional or sales materials and statements, as well as in the technical documentation” (CRA Art. 3(23)), and asks for it “including the security environment provided by the manufacturer” in the information that accompanies the product (Annex II point 4). The EHDS (Regulation (EU) 2025/327) asks for “its intended purpose, and the date and version of the EHR system” in the technical documentation (Annex III 1(a)) and on the information sheet (Art. 38(2)(c)), and forbids advertising that suggests uses “other than those stated to form part of the intended purpose in the technical documentation” (Art. 28(c)).

Warning

The quotations are from the Official Journal texts at EUR-Lex: the CRA, the EHDS and the MDR, Regulation (EU) 2017/745. The exact texts these pages were checked against are vendored in the FerroEHR repository under docs/law/eu/. This page says what the manufacturer intends. It does not say that the system, or a deployment of it, meets either regulation: no conformity assessment has been carried out and no EU declaration of conformity exists.

The statement, its version and its scope

Issued byCadasto B.V., Comeniusstraat 2d, 1817 MS Alkmaar, The Netherlands, info@cadasto.com
Statement versionthe revision of 2026-10-08. It takes over the system-level parts of FerroEHR’s statement version 1 of 2026-10-06
Applies tothe EHR system formed by FerroEHR (its server, images and Helm chart) and FerroBRIDGE, from the releases whose documentation links this revision
Where each version livesthe revisions page dates every change, and the text of each revision stays in the history of the FerroHEALTH repository

A change to the intended purpose is a new revision of this page, and the release notes of the release that relies on it name its date. Under the CRA, a change that “results in a modification to the intended purpose for which the product with digital elements has been assessed” is a substantial modification (CRA Art. 3(30)), so each product’s risk assessment is revised with it.

FerroFED is an EHR system of its own, with its own statement on its regulatory status page. This page does not cover it.

What the EHR system is for

The EHR system stores, versions and queries the structured health records of one healthcare provider, serves them to the software that provider’s health professionals and patients use, and exchanges them in the European electronic health record exchange format. It has no clinical user interface of its own: health professionals reach it through the clinical applications the provider connects to it.

EHDS Art. 2(2)(k) defines an EHR system as “any system whereby the software, or a combination of the hardware and the software of that system, allows personal electronic health data that belong to the priority categories of personal electronic health data established under this Regulation to be stored, intermediated, exported, imported, converted, edited or viewed, and intended by the manufacturer to be used by healthcare providers when providing patient care or by patients when accessing their electronic health data”. EHDS Art. 25(1) asks an EHR system to include both harmonised software components, and the two products carry one each:

ComponentProductWhat it does
European logging software component (EHDS Art. 2(2)(o), Annex II point 3)FerroEHRholds the records as openEHR compositions with their full version history, serves them through the openEHR REST API and the Archetype Query Language, and records every access to them in its access log
European interoperability software component (EHDS Art. 2(2)(n), Annex II points 2.1 to 2.3)FerroBRIDGEholds the mappings from openEHR to the European electronic health record exchange format and reads FerroEHR over the openEHR REST API. The format itself is set by implementing acts under EHDS Art. 15(1), which have not been adopted

The EHDS defines each component as independent of the other. FerroEHR and FerroBRIDGE are separate products that meet only over the openEHR REST API. FerroEHR documents the logging component’s requirements and the system-level ones of Annex II point 1; FerroBRIDGE documents the interoperability component’s.

Who uses it

UserHow they use the EHR system
A healthcare provider, the deploying organisationruns the system for its own records, as controller of the data in it. Its operators install, configure, upgrade and monitor each product
Developers of clinical applicationsconnect an application to FerroEHR’s REST API and AQL, on behalf of the provider
Health professionalsuse the system only through those applications. The application’s caller is authenticated by the provider’s identity provider, and FerroEHR authorises each request and records it
Patientsdo not use the system directly. A patient reads their record, and the log of who accessed it, through an electronic health data access service, which EHDS Art. 4(1) has the Member States establish. FerroEHR serves one patient’s access log to such a service when the deployment configures it
Clinical modellers and administratorsload templates, write stored queries, maintain the mappings and run the operational surfaces of each product

The data the EHR system is designed to process

EHDS Annex III 1(b) and Art. 38(2)(d) ask for “the categories of personal electronic health data that the EHR system has been designed to process”. The system is designed for the priority categories of EHDS Art. 14(1): “(a) patient summaries; (b) electronic prescriptions; (c) electronic dispensations; (d) medical imaging studies and related imaging reports; (e) medical test results, including laboratory and other diagnostic results and related reports; and (f) discharge reports”, and any category a Member State adds in national law. Which of them a deployment holds depends on the templates it loads, and the deployment declares that. Beside the clinical content, the system holds the identities of the record subjects, the link between the two, and the access log.

Each product’s book lists the data it holds, domain by domain: FerroEHR’s.

How the EHR system is operated

The system runs in one of two ways:

  • Self-hosted. The deploying organisation installs and runs it, or has a processor of its own choosing do so. Cadasto B.V. is the manufacturer only and has no access to the deployment or its data.
  • Hosted by Cadasto B.V. Cadasto B.V. may run the system as a service for an organisation. It is then also the operator, and that organisation’s processor under a contract that GDPR Art. 28(3) requires. An EHR system offered as a service to a person established in the Union “shall be considered as having been put into service” (EHDS Art. 26(2)).

In both cases each organisation gets its own instance of each product. The environment each product relies on and does not provide itself, such as TLS termination, an identity provider and database protection, is stated in that product’s book (CRA Annex II point 4): FerroEHR’s security environment.

What the intended purpose excludes

  • Medical device purposes. Cadasto B.V. does not intend the EHR system for any of the “specific medical purposes” in the MDR’s definition of a medical device (MDR Art. 2(1)): “diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of disease”, and the others that article lists. The system stores, returns and converts records; it computes no diagnosis, score, alert or treatment advice.
  • Several organisations in one deployment. One deployment serves one healthcare provider.

Each product’s book lists the exclusions particular to it, and the use and misuse that can be foreseen for it.

Where this statement is used

  • Each product’s CRA risk assessment analyses its risks “based on the intended purpose and reasonably foreseeable use” (CRA Art. 13(3)): FerroEHR’s.
  • The hazard log of the logging component assesses patient safety “during normal conditions of use” (EHDS Annex II 1.1): FerroEHR’s hazard log.
  • The claims review checks every public text against it (EHDS Art. 28(c)): FerroEHR’s.
  • The technical documentation maps EHDS Annex III 1(a) onto it, and the information sheet of EHDS Art. 38 repeats it: FerroEHR’s technical documentation and information sheet.

FerroBRIDGE’s book carries none of these pages yet.